Active Ingredient: ABACAVIR SULFATE; LAMIVUDINE
Proprietary Name: ABACAVIR SULFATE AND LAMIVUDINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 600MG BASE;300MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A208990
Product Number: 001
Approval Date: Nov 15, 2018
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
